Speaker illustration

Doctor Jonathan Sen

Baker Heart and Diabetes Institute, Melbourne (Australia)

Member of:

European Society of Cardiology

CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Scores

Session: Atrial Fibrillation, Platelet Aggregation and Outcomes

Thumbnail

Effects of patient characteristics and comorbidities on temporal trends of low-flow, low-gradient aortic stenosis phenotypes

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular Heart Disease ePosters

Thumbnail

Clinical outcomes from antihypertensive therapies in moderate or severe aortic stenosis: a systematic review and meta-analysis

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pharmacotherapy

Session: Valvular Heart Disease ePosters

Thumbnail

CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial

Event: ESC Asia with APSC & AFC 2020

Topic: Scores

Session: Abstract Programme

Thumbnail

This platform is supported by

logo Novo Nordisk